BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) today announced that Thomas C. Reynolds, M.D., Ph.D., has joined the company as Chief Medical Officer. In this role, Dr. Reynolds will oversee clinical and regulatory activities across the company’s product portfolio focused on cancer and autoimmune disease.
